HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jos H Beijnen Selected Research

5'-deoxy-5-fluorocytidine

12/2019Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis.
4/2010A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jos H Beijnen Research Topics

Disease

230Neoplasms (Cancer)
08/2022 - 01/2002
112Breast Neoplasms (Breast Cancer)
01/2022 - 09/2002
28Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2002
18Neutropenia
01/2022 - 05/2002
17Brain Neoplasms (Brain Tumor)
01/2022 - 07/2003
15Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2005
14Visceral Leishmaniasis (Kala Azar)
08/2022 - 01/2012
14Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 03/2006
14Renal Cell Carcinoma (Grawitz Tumor)
05/2020 - 02/2007
14Neoplasm Metastasis (Metastasis)
01/2020 - 11/2002
13Melanoma (Melanoma, Malignant)
02/2020 - 12/2003
11Nausea
01/2020 - 10/2005
10Glioblastoma (Glioblastoma Multiforme)
01/2020 - 05/2007
10Glioma (Gliomas)
11/2018 - 12/2009
10Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 01/2002
9Sarcoma (Soft Tissue Sarcoma)
05/2020 - 05/2007
9Hypertension (High Blood Pressure)
01/2017 - 01/2009
8Leishmaniasis
08/2022 - 08/2008
8Vomiting
12/2016 - 10/2005
8Overweight
01/2015 - 01/2009
7Fatigue
12/2016 - 08/2006
7Carcinoma (Carcinomatosis)
09/2016 - 10/2003
6Dihydropyrimidine Dehydrogenase Deficiency
01/2022 - 01/2012
6Cutaneous Leishmaniasis
01/2022 - 08/2008
6Exanthema (Rash)
01/2020 - 09/2003
6Thrombocytopenia (Thrombopenia)
01/2020 - 06/2005
5Hepatocellular Carcinoma (Hepatoma)
01/2020 - 02/2006
5Diarrhea
01/2020 - 09/2011
5Body Weight (Weight, Body)
10/2017 - 05/2002
5Dementia (Dementias)
01/2016 - 12/2005
5Glucose Intolerance
01/2014 - 05/2011
5Infections
12/2011 - 09/2002
5Renal Insufficiency (Renal Failure)
09/2011 - 05/2002
4Neglected Diseases
08/2022 - 03/2012
4Disease Progression
01/2022 - 11/2007
4Carcinogenesis
02/2021 - 09/2005

Drug/Important Bio-Agent (IBA)

85Pharmaceutical PreparationsIBA
08/2022 - 03/2002
67Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2002
45Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 04/2004
29Docetaxel (Taxotere)FDA Link
01/2022 - 02/2003
27Biomarkers (Surrogate Marker)IBA
10/2021 - 03/2005
20Paclitaxel (Taxol)FDA LinkGeneric
04/2021 - 07/2003
18Tyrosine Kinase InhibitorsIBA
06/2020 - 05/2007
17Carboplatin (JM8)FDA LinkGeneric
01/2021 - 09/2002
15Capecitabine (Xeloda)FDA Link
05/2020 - 03/2004
15GemcitabineFDA Link
02/2015 - 11/2002
14miltefosine (Impavido)IBA
01/2022 - 08/2008
13EnzymesIBA
01/2022 - 10/2002
13ElacridarIBA
01/2018 - 07/2003
12Cytochrome P-450 CYP3AIBA
01/2022 - 01/2006
12PlatinumIBA
02/2021 - 05/2002
11Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 09/2002
11TamoxifenFDA LinkGeneric
10/2021 - 06/2011
11Cisplatin (Platino)FDA LinkGeneric
02/2021 - 03/2002
11Blood Proteins (Serum Proteins)IBA
10/2012 - 03/2006
10Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 01/2006
10Ritonavir (Norvir)FDA Link
01/2021 - 11/2002
9Phosphotransferases (Kinase)IBA
01/2022 - 08/2010
9Monoclonal AntibodiesIBA
02/2021 - 08/2009
9Adenosine Triphosphate (ATP)IBA
01/2018 - 11/2002
8Peptides (Polypeptides)IBA
10/2021 - 01/2010
8Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2021 - 08/2008
8pazopanibFDA Link
01/2020 - 01/2012
8DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2004
8TrabectedinIBA
12/2009 - 01/2002
7Imatinib Mesylate (Gleevec)FDA Link
08/2020 - 05/2007
7Trastuzumab (Herceptin)FDA Link
02/2016 - 08/2009
7N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
10/2011 - 09/2002
7Topotecan (Hycamtin)FDA LinkGeneric
07/2009 - 01/2002
7Nevirapine (Viramune)FDA Link
07/2005 - 09/2002
6Hormones (Hormone)IBA
01/2022 - 01/2012
6Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022 - 10/2015
6Anaplastic Lymphoma KinaseIBA
01/2021 - 03/2014
6ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021 - 11/2002
6Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2020 - 10/2013
6taxaneIBA
01/2019 - 04/2004
64-hydroxy-N-desmethyltamoxifenIBA
12/2018 - 06/2011
6Sunitinib (Sutent)FDA Link
05/2015 - 01/2012
6imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA
02/2015 - 11/2002
6ATP-Binding Cassette Sub-Family B Member 4IBA
10/2013 - 01/2006
6Glucose (Dextrose)FDA LinkGeneric
01/2013 - 01/2009
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2009 - 09/2002
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 08/2008
5Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2022 - 10/2005
5EverolimusFDA Link
01/2022 - 08/2012
5Taxoids (Taxanes)IBA
04/2021 - 09/2005
5olaparibIBA
01/2021 - 07/2011
5Cetuximab (Erbitux)FDA Link
02/2020 - 02/2010
5Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2016 - 08/2007
5RutheniumIBA
02/2015 - 11/2002
5Triglycerides (Triacylglycerol)IBA
07/2013 - 05/2009
4TropomyosinIBA
01/2022 - 12/2018

Therapy/Procedure

60Therapeutics
10/2021 - 11/2002
30Drug Therapy (Chemotherapy)
02/2021 - 09/2002
11Castration
01/2022 - 01/2019
8Lasers (Laser)
07/2012 - 12/2003
7Oral Administration
10/2021 - 06/2004
6Drug Tapering
10/2019 - 05/2007
5Intravenous Administration
08/2020 - 05/2007
5Radiotherapy
11/2018 - 08/2006